Viatris | VTRS - PE Price to Earnings

Stock Price
14.70
Daily Change
0.11 0.75%
Monthly
13.43%
Yearly
78.18%
Q2 Forecast
14.28

Viatris reported 10.4 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
Celltrion 50.09 23.24 Sep/2025
Cspc Pharmaceutical 24.4 1.13 Dec/2025
Deva Holding AS 6.55 2.01 Sep/2023
Dianthus Therapeutics 3.8 1.53 Sep/2024
Divis Laboratories Ltd 66.5 5.69 Dec/2025
Kangmei Pharma 3.15K 624.19 Jun/2025
Knight Therapeutics 257.34 166.24 Dec/2025
Laboratorios Farma 18.78 6.64 Dec/2023
Malin Corporation 11.81 0.72 Jun/2023
Neuren Pharmaceuticals 72.14 59.86 Dec/2025
Organigram Holdings 235 224.49 Sep/2025
Ovoca Bio 1.83 3.29 Jun/2024
Pharma Mar 17.41 29.74 Dec/2025
Qiagen NV 20.54 0.1 Dec/2025
Sartorius 43.44 84.64 Mar/2026
Sino Biopharmaceutical 17.03 0.89 Jun/2025
Tilray 11.56 80.19 Sep/2025
Viatris 10.4 11.84 Sep/2025
Zealand Pharma A/S 5.13 0.16 Dec/2025
Zz Pientze Pharmaceu 49.04 4.33 Sep/2025